Global Allergy Diagnostics Market valued at USD 4.9 billion in (2021), is set to witness a significant growth of 11% in upcoming 5 years

The prevalence of allergic diseases globally has continued to grow in the industrialized world for more than 50 years. Allergies are the 6th leading cause of chronic illness in the U.S. and each year more than 50 million Americans experience various types of allergies. Continuously rising cases of allergic diseases and other related medical conditions has fueled the global allergy diagnostics market.

Growing Prominence of mHealth in Allergy Diagnosis & Allergy Care

The widespread availability of technology-based interventions such as mobile health in the clinical setting has enabled patients to play an active role in their medical care. Mobile health (mHealth) utilizes mobile communication devices such as computers, tablets and smartphones to improve patient education & self-management of diseases, help in remote surveillance of patient’s health, flow of data and information and disease management from first diagnosis to an optimized treatment.

Advent of patient-facing mHealth technologies (such as apps) is expected to favorably impact clinical, economic and process outcomes. Features such as medication reminders, educational content, games-based self management, symptom diaries, electronic sensors, patient self-tracking dashboards, voice recognition, wearable technology, pollen sensors, and virtual reality offered by apps not only improves patient knowledge but also improves medication adherence, asthma and allergic conditions control, quality of life and results in fewer unscheduled office visits.

mHealth offers allergists and patients a new mode of communication via the phone camera, sound recording system, motion sensors, texting, and by using diagnostic devices and diagnostic algorithms incorporated in the smartphone itself.

Competitive Landscape Analysis: Allergy Diagnostics Market

The key players operating in the allergy diagnostics market are Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher, Omega Diagnostics Group PLC, bioMérieux SA, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, NEOGEN Corporation, Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, HOB Biotech Group Corp., Ltd., HYCOR Biomedical, R-Biopharm AG, AESKU.GROUP GmbH, ACON Laboratories, Inc., Lincoln Diagnostics, Inc., Astra Biotech GmbH, Erba Group (UK), among others.

Growing cases of allergic diseases (asthma, allergic rhinitis, atopic dermatitis, and food allergy), rising environmental pollution levels, high volume consumption of processed food and beverages, advent of mHealth in allergy diagnosis & care and growing awareness about allergic diseases are some of the key factors driving the Global Allergy Diagnostics Market.

Get Customized Report on Allergy Diagnostics Market @ https://meditechinsights.com/allergy-diagnostics-market/

Comments

Post a Comment

Popular posts from this blog

Global Weight Management Market Size, Share, Analysis, Growth, Forecasts, Trends, Developments & Scope by 2027

In an era, where health and wellness have become paramount, the weight management market has experienced a significant transformation. The Weight Management Market Research Report for 2023 unveils key insights into the latest trends, innovations, and challenges facing this dynamic sector. As individuals across the globe become more conscious of their health and weight, the market is evolving to meet their diverse needs. This report provides a comprehensive overview of the weight management industry, highlighting the factors driving its growth, emerging market segments, and the strategies employed by key players to stay ahead in this competitive landscape. Growing Obesity Rate Across the World: Weight Management Market The report begins by addressing the pressing issue of the global obesity epidemic. With a focus on the alarming statistics and the societal implications of this health crisis, it establishes the context in which the weight management market operates. The report delves in...
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge...
Read more

Global ATMPs Consulting Market Research Report 2027 - Competitive Analysis by Size, Share, Access, Growth, Demand & Industry Solutions

Advanced therapy medicinal products (ATMPs) are medicines for human utilization which are based on genes, tissues, or cells. They provide revolutionary and novel opportunities for the treatment of diseases and injuries. ATMPs primarily target diseases with unfulfilled medical demands. It has an extensive therapeutic potential for treating multiple types of diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases. Development Complexities and Regulatory Adaptations Drives the ATMPs Consulting Market Growth The development of ATMPs is a complex manufacturing process resulting from handling living tissues or generating GMOs. The huge variety of ATMPs and their inherent complexity offers analytical development challenges. Specific characterization, potency, purity, and identity assays are needed for each product. Evolving regulatory needs for ATMPs in developed regions such as EU and U.S. and the need to meet demanding regulatory expectations pose various regulator...
Read more